# Correction: Schmitz et al. The Precision-Guided Use of PI3K Pathway Inhibitors for the Treatment of Solid Malignancies. Biomedicines 2025, 13, 1319

**Authors:** Alexa E. Schmitz, Shirsa Udgata, Katherine A. Johnson, Dustin A. Deming

PMC · DOI: 10.3390/biomedicines13112627 · 2025-10-27

## Full-text entities

- **Genes:** PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}
- **Diseases:** Solid Malignancies (MESH:D009369)

---
Source: https://tomesphere.com/paper/PMC12650268